3 Metabolism of Xenobiotics by the Liver Flashcards

1
Q

Xenobiotics

A
  • Xenobiotics are substances foreign to the host
  • Many xenobiotics are non-polar and lipophilic
  • Require modification to make them polar, water soluble and easier to excrete
  • Non-natural molecules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Factors That Affect Absorption

A
  • Lipophilicity versus hydrophilicity
  • Relative concentration on the either side of the membrane
  • High concentration of the xenobiotic and slow movement within the GIT favours absorption
  • Association with food
  • The ionisation of the xenobiotic, i.e. is it a salt
  • Membrane proteins have +ve and –ve charged residues designed to repel xenobiotics
  • Local pH controls: weak acids are absorbed in the stomach, whereas weak bases are absorbed in the SI
  • Particle size, e.g. of the dosage form - slow release drugs may be contained in particles that are larger
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pH in stomach and small intestine

A

stomach = 2, small intestine = 5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Aspects Which Affect Distribution

A

• Dynamics of distribution depend upon:
• Drug lipophilicity
• Lipoidality of the tissue
• Blood flow through the tissue
• Mass of the tissue
• Plasma/tissue concentration gradient
• All factors are affected by sex, age and health
• Women have less water (54 vs. 60%) and more
fat (28 vs. 18%) than men, so women absorb drugs better as more drugs associate strongly with fatty tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Metabolism

A
  • The chemical modification of xenobiotics with the overall goal of ridding the body of the substance
  • Occurs mainly in the liver
  • During first pass effect there is extensive chemical transformation of lipophilic or heavy (MW >500) compounds
  • The metabolite may have:
  • Equal activity to the xenobiotic/drug
  • No or a reduced activity
  • Increased activity (prodrugs)
  • Toxicity not observed in the parent molecule
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Special Aspects of Excretion

A
  • Lactation, passage of substances from mother
  • Little excretion via faeces unless the GIT is diseased or e.g. the formulation of a drug is poor
  • Volatile agents can be excreted via the lungs
  • Passive re-absorption of lipid-soluble substances
  • Entero-hepatic shunt:
  • Glucuronic acid conjugates can be excreted in bile
  • The -glucuronidase in the GIT will hydrolyse the carbohydrate conjugate
  • Active xenobiotic may then be reabsorbed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Phase I Metabolism

A
  • Phase I metabolic reactions create functional groups that place xenobiotics in a correct chemical state to be acted upon at Phase II
  • Majority of Phase I reactions in hepatic microsomes employ cytochrome P450 (CYP) enzymes

Not all have to go through phase I they can go straight phase II.
Vast majority of Phase I are oxidations, and some reductions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cytochrome P450 (CYP) Enzymes found in

A

Gut, intestines, majority in the liver but some also in gut epithelia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
Cytochrome P450 (CYP) Enzymes
• Grouped based on..
A
  • Grouped based on structural similarities
  • CYP family has 40% sequence homology
  • CYP subfamily has 55% sequence homology
  • Individual enzymes within a subfamily denoted
  • CYP2E1 has 40% homology with other CYP2s, at least 55% homology with other CYP2Es, but is distinct from CYP2E2, CYP2E3, etc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Overall reaction of CYP P450 enzymes

A

NADPH + H+ + O2 + SubstrateH →

NADP+ + H2O + SubstrateOH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
Cytochrome P450 (CYP) Enzymes
• Humans have..
A
  • Humans have 18 families and 43 subfamilies of CYPs from 57 genes and 58 pseudogenes, CYP2 most represented
  • CYP3A4 metabolises 50% of therapeutic drugs
  • CYP2D6 metabolises ~20%
  • CYP2C9 and CYP2C19 metabolise ~15%
  • CYP1A2, CYP2A6, CYP2B6 and others ~15%
  • A substrate may be processed by more that one isoform
  • Genetic polymorphisms lead to individual metabolic profiles which can impact on chemotherapy of disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Oxidations Not Catalysed By CYPs

A
  • Aromatases
  • Alcohol dehydrogenase and aldehyde oxidation
  • Xanthine oxidase
  • Amine oxidases
  • Flavin-containing monooxygenase system
  • Mainly in liver smooth endoplasmic reticulum
  • Oxidizes compounds containing sulfur and nitrogen
  • Uses NADH and NADPH as cofactors
  • Multi-gene family, FMO3 is major human liver form
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Reductive Metabolism

A

Reductive reactions are catalysed within the liver Require NADPH and are inhibited by O2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Phase II Metabolism

A

Making metabolites water soluble so we can excrete them

Some molecules go straight to phase II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Conjugation With Carbohydrates

A
  • The most important Phase II pathway
  • Major route is conjugation with -D-glucuronic acid
  • UDP-glucuronic acid intermediate required
  • UDP-glucuronosyltransferases (UGTs, cytosol)
  • N-Glucuronidation: amines, amides, sulfonamides
  • O-Glucoronidation: carboxylic acids, phenols, alcohols
  • Products often excreted in the bile, possibility of enterohepatic recycling due to GIT enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

UDP definition

A

Universal shuttle used to carry molecules, has got 2 phosphates so high in energy. UDP is also encountered in RNA,
Glucuronic acid can be added on nitrogen and oxygen
products are excreted in bile or urine

17
Q

Sulfation

A
  • Major pathway for phenols
  • 3’-Phosphoadenosine-5’-phosphosulfate (PAPS) intermediate required
  • Sulfotransferases (SULTs, cytosol)
18
Q

Sulfation vs Glucuronidation

A
  • Two competing pathways
  • Glucuronidation predominates at high [substrate]
  • Sulfation predominates at low [substrate]
  • There is relatively less PAPS in cell cytosol compared to UDPGA
19
Q

Methylation

A
  • S-adenosylmethionine (SAM)

* N-, O- and S-methyltransferases

20
Q

Acetylation

A
  • Substrates include aromatic amines and sulfonamides
  • Requires acetyl CoA
  • Takes place mainly in Kupffer cells in the liver
  • N-acetyltransferase
21
Q

Amino Acid Conjugation

A
  • Substrate is activated by the attachment of AMP
  • This is followed by replacement of AMP with S-CoA
  • Conjugation with endogenous AAs then occurs
  • Glycine, glutamine, ornithine, arginine, taurine
22
Q

Glutathione Conjugation

A

Substrates are highly electrophilic compounds
• Glutathione-S-transferase (GSTs, cytosol)
• Conjugates are excreted in bile or via kidney
• Conjugate attacked by -glutamyltranspeptidase and a peptidase to yield the cysteine conjugate

23
Q

Fatty Acid Conjugation

A

Palmitic and stearic acids

24
Q

Are xenobiotics toxic or not?

A

• The toxicity of a xenobiotic depends upon the nature of the substance and the health and metabolic function of the individual

25
Q

Where are xenobiotics found?

A
  • Xenobiotics accumulate in different body tissues

* A mechanism for preventing the accumulation of toxic levels of xenobiotics is essential

26
Q

Can xenobiotics be terminated by metabolism?

A
  • Metabolism may not terminate the action of the xenobiotic
  • Several routes of metabolism may exist for each xenobiotic
  • Individual variations in metabolism are genetically determined